{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:39:13Z","timestamp":1793299153319,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.preghy.2020.01.011","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T20:43:51Z","timestamp":1579553031000},"page":"177-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["The flipside of hydralazine in pregnancy: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"19","author":[{"given":"Christina","family":"Antza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrisa","family":"Dimou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Doundoulakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Akrivos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Stabouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Bettina","family":"Haidich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios G.","family":"Goulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilios","family":"Kotsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.preghy.2020.01.011_b0005","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/j.ackd.2013.01.014","article-title":"The management of hypertension in pregnancy","volume":"20","author":"Kattah","year":"2013","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.preghy.2020.01.011_b0010","series-title":"WHO Recommendations for Prevention and Treatment of Pre-eclampsia and Eclampsia","author":"World Health Organization","year":"2011"},{"issue":"5","key":"10.1016\/j.preghy.2020.01.011_b0015","first-page":"1122","article-title":"Task force on hypertension in pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists\u2019 task force on hypertension in pregnancy","volume":"122","author":"American College of Obstetricians and Gynecologists","year":"2013","journal-title":"Obstet. Gynecol."},{"issue":"9543","key":"10.1016\/j.preghy.2020.01.011_b0020","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0140-6736(06)69381-1","article-title":"Lancet Maternal Survival Series steering group. Strategies for reducing maternal mortality: getting on with what works","volume":"368","author":"Campbell","year":"2006","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.preghy.2020.01.011_b0025","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005526","article-title":"Impact of antihypertensive treatment on maternal and perinatal outcomes in pregnancy complicated by chronic hypertension: a systematic review and meta-analysis","volume":"6","author":"Webster","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.preghy.2020.01.011_b0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1074248415587969","article-title":"Direct vasodilators and sympatholytic agents","volume":"21","author":"McComb","year":"2016","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.preghy.2020.01.011_b0035","unstructured":"National Institute of Health and Clinical Excellence, Hypertension in pregnancy. The management of hypertensive disorders during pregnancy. Clinical guidelines CG10Issued: August 2010 [Internet] [http:\/\/wwwniceorguk\/]."},{"issue":"7","key":"10.1016\/j.preghy.2020.01.011_b0040","article-title":"Drugs for treatment of very high blood pressure during pregnancy","author":"Duley","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7421","key":"10.1016\/j.preghy.2020.01.011_b0045","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/bmj.327.7421.955","article-title":"Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis","volume":"327","author":"Magee","year":"2003","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.preghy.2020.01.011_b0050","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/1471-0528.12737","article-title":"Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review","volume":"121","author":"Firoz","year":"2014","journal-title":"BJOG"},{"issue":"9","key":"10.1016\/j.preghy.2020.01.011_b0055","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/bcp.13649","article-title":"Drugs for treating severe hypertension in pregnancy: a network meta-analysis and trial sequential analysis of randomized clinical trials","volume":"84","author":"Sridharan","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.preghy.2020.01.011_b0060","author":"Whelton","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.preghy.2020.01.011_b0065","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.preghy.2020.01.011_b0070","unstructured":"J.P.T. Higgins, S. Green, Cochrane Handbook for Systematic Reviews of Interventions, in: J.P.T. Higgins, S. Green (Eds.), Analysing Data and Undertaking Meta-analyses, Version 5.1.0 (updated 2011), The Cochrane Collaboration (Chapter 9)."},{"key":"10.1016\/j.preghy.2020.01.011_b0075","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.preghy.2020.01.011_b0080","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"7109","key":"10.1016\/j.preghy.2020.01.011_b0085","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"20","key":"10.1016\/j.preghy.2020.01.011_b0090","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Stat Med."},{"issue":"1","key":"10.1016\/j.preghy.2020.01.011_b0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1034\/j.1600-0412.2002.810105.x","article-title":"Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia","volume":"81","author":"Aali","year":"2002","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"6","key":"10.1016\/j.preghy.2020.01.011_b0100","first-page":"354","article-title":"Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy","volume":"71","author":"Ashe","year":"1987","journal-title":"South Afr. Med. J. = Suid-Afrikaanse tydskrif vir geneeskunde"},{"issue":"4","key":"10.1016\/j.preghy.2020.01.011_b0105","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/0002-9378(93)90383-T","article-title":"Malignant ventricular arrhythmias in eclampsia: a comparison of labetalol with dihydralazine","volume":"168","author":"Bhorat","year":"1993","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2020.01.011_b0110","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejogrb.2015.02.002","article-title":"Ketanserin versus dihydralazine for the treatment of severe hypertension in early-onset preeclampsia: a double blind randomized controlled trial","volume":"189","author":"Bijvank","year":"2015","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"1","key":"10.1016\/j.preghy.2020.01.011_b0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.preghy.2013.08.001","article-title":"La Ossa K. Hydralazine vs labetalol for the treatment of severe hypertensive disorders of pregnancy. A randomized, controlled trial","volume":"4","author":"Delgado De Pasquale","year":"2014","journal-title":"Pregnancy Hypertens."},{"issue":"5","key":"10.1016\/j.preghy.2020.01.011_b0120","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1471-0528.1991.tb10339.x","article-title":"Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol","volume":"98","author":"Harper","year":"1991","journal-title":"Br. J. Obstet. Gynaecol."},{"issue":"4","key":"10.1016\/j.preghy.2020.01.011_b0125","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/j.1479-828X.2007.00738.x","article-title":"A randomised comparison of hydralazine and mini-bolus diazoxide for hypertensive emergencies in pregnancy: the PIVOT trial","volume":"47","author":"Hennessy","year":"2007","journal-title":"Austr. New Zealand J. Obstetr. Gynaecol."},{"issue":"1","key":"10.1016\/j.preghy.2020.01.011_b0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1515\/jpme.1993.21.1.69","article-title":"Neonatal adaptation in hypertensive pregnancy\u2013a study of labetalol vs hydralazine treatment","volume":"21","author":"Hjertberg","year":"1993","journal-title":"J. Perinat. Med."},{"issue":"2","key":"10.1016\/j.preghy.2020.01.011_b0135","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/10641959709031638","article-title":"A randomized controlled pilot study comparing urapidil to dihydralazine in the management of severe hypertension in pregnancy","volume":"16","author":"Howarth","year":"1997","journal-title":"Hypertens. Pregnancy"},{"issue":"2","key":"10.1016\/j.preghy.2020.01.011_b0140","first-page":"466","article-title":"Comparison of Hydralazine and Labetalol to lower severe hypertension in pregnancy","volume":"33","author":"Khan","year":"2017","journal-title":"Pakistan J. Med. Sci."},{"issue":"3 Pt 1","key":"10.1016\/j.preghy.2020.01.011_b0145","first-page":"328","article-title":"A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy","volume":"70","author":"Mabie","year":"1987","journal-title":"Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2020.01.011_b0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10641959709069085","article-title":"A comparative study of intravenous isradipine and dihydralazine in the treatment of severe hypertension of pregnancy in black patients","volume":"16","author":"Maharaj","year":"1997","journal-title":"Hypertens. Pregnancy"},{"issue":"1","key":"10.1016\/j.preghy.2020.01.011_b0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/10641959209031031","article-title":"Randomized, controlled trial of hydralazine versos nifedipine in preeclamptic women with acute hypertension","volume":"11","author":"Martins-Costa","year":"1992","journal-title":"Clin. Exp. Hypertens. Part B: Hypertens. Pregnancy"},{"issue":"9","key":"10.1016\/j.preghy.2020.01.011_b0160","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1471-0528.1992.tb13872.x","article-title":"A comparative study of the use of epoprostenol and dihydralazine in severe hypertension in pregnancy","volume":"99","author":"Moodley","year":"1992","journal-title":"Br. J. Obstet. Gynaecol."},{"issue":"2","key":"10.1016\/j.preghy.2020.01.011_b0165","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/14767058.2014.995081","article-title":"Impedance cardiography assessed treatment of acute severe pregnancy hypertension: a randomized trial","volume":"29","author":"Morris","year":"2016","journal-title":"J. Maternal-fetal Neonatal Med.: official J. Eur. Assoc. Perinatal Med. Federation Asia Oceania Perinatal Soc. Int. Soc. Perinatal Obstet."},{"issue":"6","key":"10.1016\/j.preghy.2020.01.011_b0170","first-page":"525","article-title":"Ketanserin and hydralazine in hypertension in pregnancy\u2013a randomised double-blind trial","volume":"85","author":"Rossouw","year":"1995","journal-title":"South Afr. Med. J. = Suid-Afrikaanse tydskrif vir geneeskunde"},{"issue":"6","key":"10.1016\/j.preghy.2020.01.011_b0175","doi-asserted-by":"crossref","first-page":"687 e1","DOI":"10.1016\/j.ajog.2017.08.018","article-title":"Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized controlled trial","volume":"217","author":"Sharma","year":"2017","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.preghy.2020.01.011_b0180","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0301-2115(97)00123-1","article-title":"Dihydralazine or ketanserin for severe hypertension in pregnancy? Preliminary results","volume":"75","author":"Steyn","year":"1997","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"1\u20132","key":"10.1016\/j.preghy.2020.01.011_b0185","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejogrb.2006.02.015","article-title":"Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial","volume":"128","author":"Vigil-De Gracia","year":"2006","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"2","key":"10.1016\/j.preghy.2020.01.011_b0190","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/oxfordjournals.ndt.a027825","article-title":"Treatment of hypertension in patients with pre-eclampsia: a prospective parallel-group study comparing dihydralazine with urapidil","volume":"13","author":"Wacker","year":"1998","journal-title":"Nephrology Dialysis Transplantation: Official Publ. Eur. Dialysis Transplant Assoc. \u2013 Eur. Renal Assoc."},{"key":"10.1016\/j.preghy.2020.01.011_b0195","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.preghy.2018.05.004","article-title":"The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice","volume":"13","author":"Brown","year":"2018","journal-title":"Pregnancy hypertens."},{"key":"10.1016\/j.preghy.2020.01.011_b0200","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehy339","article-title":"ESC\/ESH Guidelines for the management of arterial hypertension","author":"Williams","year":"2018","journal-title":"Eur. Heart J."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221077892030012X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221077892030012X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:53:26Z","timestamp":1761897206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221077892030012X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":40,"alternative-id":["S221077892030012X"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2020.01.011","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The flipside of hydralazine in pregnancy: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2020.01.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}